The global point-of-care (POC) diagnostics market size is expected to reach USD 23.36 billion by 2027, exhibiting a CAGR of 7.3% during the forecast period. The growing acceptance of POC testing kits in the treatment of acute and chronic diseases will spur ruminative opportunities for the global market, states Fortune Business Insights, in a report, titled “Point-of-care (POC) Diagnostics Market Size, Share & COVID-19 Impact Analysis, By Product (Blood Glucose Monitoring, Infectious Diseases, Cardiometabolic Diseases, Pregnancy & Infertility Testing, Hematology Testing, and Others), By End User (Hospital Bedside, Physicians Office Lab, Urgent Care & Retail Clinics, and Homecare/Self-Testing), and Regional Forecast, 2020-2027.” The market size stood at USD 18.45 billion in 2019.
The occurrence of coronavirus has exerted massive economic stress onto sectors in various countries. We understand that this health emergency has negatively impacted various sectors across the globe. Rising support from governments and several companies can help in the fight against this highly infectious virus. There are some industries that are struggling and some are thriving. More or less, nearly every sector is estimated to be impacted by this pandemic.
We are perpetually working on our reports to help uplift businesses in this crucial time. Our expertise and experience can offer enormous benefits to help regain during this global pandemic.
Request a Sample Copy of Research Report: https://www.fortunebusinessinsights.com/industry-reports/point-of-care-diagnostics-market-101072
June 2020: Celltrion Group announced the launch of the SARS-CoV-2 point-of-care antigen diagnostic kit. The new development will help the company increase its access to COVID-19 diagnosis management and treatment globally.
Introduction of Advanced Testing Kits to Enhance Market Scope
The growing cases of diseases such as diabetes, infectious disease, HIV, and others have urged pharmaceutical companies to introduce innovative testing kits, which, in turn, will enable the growth of the market. For instance, in June 2019, Abbott announced the release of the Afinion HbA1c Dx assay. This assay is the first of its kind point-of-care test that has been approved by the U.S FDA for the diagnosis of diabetes. Moreover, in February 2019, DiabetOmics introduced the point-of-care test Lumella for the accurate diagnosis of preeclampsia in pregnant women.
Launch of COVID-19 POC kits by Biotechnology companies to Intensify Market Amid COVID-19
COVID-19 has had a drastic effect on the healthcare industry, both negatively and positively. However, the launch of COVID-19 POC kits for coronavirus diagnosis by pharmaceutical and biotechnology companies will enable speedy expansion of the market. For instance, in July 2020 BD (Becton, Dickinson, and Company) announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for rapid, point-of-care, SARS-CoV-2 diagnostic test for use with its broadly available BD Veritor Plus System.
Quick Buy Point of Care Diagnostics Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101072
Growing Adoption of POC solutions to Boost Market in North America
The market size in North America stood at USD 6.65 billion in 2019. The growth in the region is attributed to the increasing adoption of advanced point of care diagnostics solutions for the detection of various infectious diseases. Moreover, the strategic partnerships and collaborations among major organizations will further aid the development of the market in North America.
For instance, in September 2020, a global partnership between World Health Organization (WHO), Africa Centers for Disease Control and Prevention (Africa CDC), the Bill & Melinda Gates Foundation, the Clinton Health Access Initiative (CHAI), the Foundation for Innovative New Diagnostics (FIND), and the Global Fund together announced to provide access to COVID-19 rapid test in the low and middle-income countries. The market in Europe is expected to expand radically during the forecast period owing to its growing efforts of companies to provide advanced rapid diagnostic solutions. For instance, in November 2019, Linear Diagnostics received investments of $2.6 million and planned to collaborate with the University of Birmingham, the U.K. to develop an optical point-of-care diagnostic testing platform for sexually transmitted diseases.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/point-of-care-diagnostics-market-101072
The report on thepoint-of-care (POC) diagnostics market Depicts:
- Prominent understandings of the market
- Swot Analysis of the regions
- Latest market trends and developments
- Stellar insights into the competitive landscape
- Prime data about regional players
- Coronavirus impact
The Report Lists the Key Companies in the Point-of-care (POC) Diagnostics Market:
- Hoffmann-La Roche Ltd (Basel, Switzerland)
- Thermo Fisher Scientific Inc. (Massachusetts, U.S.)
- Abbott Laboratories (Illinois, U.S)
- Quest Diagnostics Incorporated (New Jersey, United States)
- BD (Franklin Lakes, U.S)
- bioMérieux SA (Marcy l’Etoile, France)
- Cardinal Health, Inc. (Ohio, U.S)
- Mesa Biotech (California, U.S)
- Cepheid (California, U.S)
- Trinity Biotech (Bray, Ireland)
- Quidel Corporation (San Diego, U.S.)
- Bio-Rad Laboratories Inc. (California, U.S)
- Other Players
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/point-of-care-diagnostics-market-101072
Detailed Table of Content:
- Market Scope
- Market Segmentation
- Market Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence of Key Disease Indications– For Key Country/Region
- Technological Advancements in the Point-of-care (POC) Diagnostics
- New Product Launch
- Overview of Regulatory Scenario
- Key Industry Developments – Mergers, Acquisitions, and Partnerships
- Overview of COVID-19 Impact on POC Diagnostics Market
- Major Factors Driving the Impact of COVID-19
- Reimbursement Changes in Response to COVID-19 Impact
- Opportunities Offered by the Impact of COVID-19
- Global Point of care (POC) Diagnostics Market Analysis, Insights and Forecast, 2017-2028
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Product
- Blood Glucose Monitoring
- Infectious Diseases
- Cardiometabolic Diseases
- Pregnancy & Infertility Testing
- Hematology Testing
- Market Analysis, Insights and Forecast – By End User
- Hospital Bedside
- Physician’s Office Lab
- Urgent Care & Retail Clinics
- Market Analysis, Insights and Forecast – By Geography
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123